Similar Articles |
|
American Family Physician January 15, 2006 Hollander-Rodriguez & Calvert |
Hyperkalemia Hyperkalemia is a potentially life-threatening metabolic problem caused by inability of the kidneys to excrete potassium, impairment of the mechanisms that move potassium from the circulation into the cells, or a combination of these factors. |
American Family Physician January 1, 2003 Edward Onusko |
Diagnosing Secondary Hypertension Secondary hypertension is elevated blood pressure that results from an underlying, identifiable, often correctable cause. Only about 5 to 10 percent of hypertension cases are thought to result from secondary causes. The ABCDE mnemonic can be used to help determine a secondary cause of hypertension. |
American Family Physician January 15, 2001 James C. Higgins & James M. Fitzgerald |
Evaluation of Incidental Renal and Adrenal Masses Incidental renal or adrenal masses are sometimes found during imaging for problems unrelated to the kidneys and adrenal glands. Knowledgeable family physicians can reliably diagnose these masses, thereby avoiding unnecessary worry and procedures for their patients... |
American Family Physician September 1, 2003 Magill et al. |
New Developments in the Management of Hypertension Advances in the management of hypertension have refined our understanding of systolic blood pressure, nutrition, medication selection, and hypertension in special populations. |
American Family Physician April 15, 2001 Robert E. Hoyt & Lester Shawn |
Reducing Readmissions for Congestive Heart Failure Hospital admission for congestive heart failure is extremely common and quite expensive, although it is frequently preventable... |
American Family Physician August 1, 2002 Daphne P. Bicket |
Using ACE Inhibitors Appropriately Although angiotensin-converting enzyme (ACE) inhibitors have documented clinical benefits in a variety of clinical situations, the disparity between the evidence from clinical trials and bedside medicine is well documented. |
American Family Physician March 1, 2007 Majeroni & Patel |
Autoimmune Polyglandular Syndrome, Type II Autoimmune polyglandular syndrome, type II (APS II) is not a common disease, but it has life-threatening consequences when the diagnosis is overlooked. |
American Family Physician October 15, 2001 Katherine L. Margo |
Spironolactone in Left-Sided Heart Failure: How Does It Fit In? The familiar diuretic spironolactone has taken on new life as a treatment for left-sided congestive heart failure. More research is necessary to determine the order and combinations of spironolactone and other medications in slowing the progression of this disease... |
American Family Physician September 15, 2001 |
Guideline for the Management of Heart Failure Caused by Systolic Dysfunction: Part II. Treatment Treatment recommendations for patients with left ventricular systolic dysfunction... |
Nursing February 2010 Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Nursing June 2011 Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
American Family Physician November 15, 2004 Charles T. Taylor |
Eplerenone (Inspra) for Hypertension Eplerenone, a potassium-sparing diuretic similar to spironolactone, selectively blocks aldosterone to lower blood pressure. However, its safety profile is improved over spironolactone because of reduced progesterone and androgen-receptor effects. |
HHMI Bulletin May 2011 Elise Lamar |
Sequencing Adrenal Tumors A global team of researchers showed that potassium channel mutations promote tumor formation and hypertension. |
AskMen.com James Fell |
Glenn Beck's 'Adrenal Fatigue' I'm not sure what's wrong with him, but he's not going to find out by taking advice from an alternative medicine practitioner pushing pseudoscience. |